# Disruption of Lrpprc affects B cell development and proliferation in a mouse model of Leigh Syndrome French Canadian type

**Authors:** Adrien Fois, Sonia Deschênes, Capucine Bourel, Claudine Beauchamp, Félix Lombard-Vadnais, Matthieu Ruiz, Guy Charron, Lise Coderre, Christine Des Rosiers, Christine Des Rosiers, Azadeh Alikashani, Bruce G. Allen, Chantale Aubut, Chantal Bémeur, Yan Burelle, François Labarthe, Jeannine Landry, Catherine Laprise, Geneviève Lavallée, Pierre Lavoie, Bruno Maranda, Charles Morin, Yvette Mukaneza, Tamiko Nishimura, Marie-Ève Rivard, Florin Sasarman, Eric A. Shoubridge, Jessica Tardif, Julie Thompson Legault, Nancy Tremblay, Vanessa Tremblay-Vaillancourt, Luc Vachon, Josée Villeneuve, John D. Rioux, Sylvie Lesage

PMC · DOI: 10.1007/s44162-025-00094-x · 2025-07-01

## TL;DR

This study shows that disruption of the Lrpprc gene in mice leads to B cell dysfunction and metabolic issues, resembling Leigh Syndrome French Canadian.

## Contribution

A viable mouse model reveals Lrpprc's essential role in B cell development and immune function in a metabolic disease context.

## Key findings

- Systemic deletion of Lrpprc in mice causes weight loss, increased lactate, and mortality.
- Lrpprc disruption strongly impairs B cell development and proliferation.
- A knock-in mouse model carrying an LSFC variant is viable for studying immune dysfunction.

## Abstract

Leigh Syndrome French Canadian (LSFC) is a rare autosomal recessive metabolic disorder characterized by severe lactic acidosis crises and early mortality. LSFC patients carry variants in the Leucine Rich Pentatricopeptide Repeat Containing (LRPPRC) nuclear gene, which lead to defects in the respiratory chain complexes and mitochondrial dysfunction. Mitochondrial respiration modulates cellular metabolic activity, which impacts many cell processes, including the differentiation and function of immune cells. The purpose of this study is to define the role of Lrpprc on immune cell function.

As genetic deletion of Lrpprc is not viable, we generated two conditional mouse models: a model for systemic deletion of Lrpprc and a knock-in (KI) model carrying the most common LSFC pathogenic variant in Quebec, NM_133259.4(LRPPRC):c.1061C > T (p.Ala354Val).

We demonstrate that Lrpprc is an essential gene even in adult mice, as systemic deletion of Lrpprc leads to prominent weight loss and mortality. We also find an increase in lactate levels, a symptom of metabolic crises in LSFC. Lrpprc deletion and pathogenic variant affect various immune cell subsets, with a strong impact on B cell development and proliferation.

We generated a viable disease-relevant mouse model to study the role of Lrpprc in vivo and find that disruption of Lrpprc strongly impairs B cell development and proliferation.

The online version contains supplementary material available at 10.1007/s44162-025-00094-x.

## Linked entities

- **Genes:** LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128], LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128]
- **Diseases:** lactic acidosis (MONDO:0006040)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Lrpprc (leucine-rich PPR-motif containing) [NCBI Gene 72416] {aka 3110001K13Rik, Gp130, Lrp130, Lsfc}
- **Diseases:** Leigh Syndrome (MESH:D007888), autosomal recessive metabolic disorder (MESH:D008659), defects (MESH:D000013), chain complexes (MESH:D028361), Canadian (MESH:C537004), weight loss (MESH:D015431), lactic acidosis (MESH:D000140)
- **Chemicals:** lactate (MESH:D019344)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Ala354Val
- **Cell lines:** NM_133259.4 — Bos taurus (Bovine), Finite cell line (CVCL_3074)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12209026/full.md

---
Source: https://tomesphere.com/paper/PMC12209026